ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,646.04
1.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Crossject (ALCJ) Quote

Crossject

Crossject (ALCJ)

EU
2.23
0.25
(12.63%)
Closed May 04 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.23
Bid
2.22
Ask
2.23
Volume
162,048
1.98 Day's Range 2.28
1.828 52 Week Range 5.96
Market Cap
119.481M
Previous Close
1.98
Open
1.98
Last Trade
138
@
2.23
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
96,737
Shares Outstanding
36,763,256
Dividend Yield
-
PE Ratio
-10.71
Earnings Per Share (EPS)
-0.3
Revenue
3.14M
Net Profit
-11.16M

About Crossject

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Website
www.crossject.com
Headquarters
Dijon, Cote-d'or, Fra
Founded
1970
Crossject is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALCJ. The last closing price for Crossject was 1.98 €. Over the last year, Crossject shares have traded in a share price range of 1.828 € to 5.96 €.

Crossject currently has 36,763,256 shares outstanding. The market capitalization of Crossject is 119.48 € million. Crossject has a price to earnings ratio (PE ratio) of -10.71.

ALCJ Latest News

More News

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

Extended contract now covers a total of 11 European countries Crossject will receive milestone payments of up to €1 million in total, upon marketing authorizations Crossject will sell ZEPIZURE®...

May 02 2024
GlobeNewswire Inc.

Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe

Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe Le contrat couvre désormais un total de 11 pays européens Crossject recevra des...

May 02 2024
GlobeNewswire Inc.

Crossject annonce le lancement d’une augmentation de capital

Crossject annonce le lancement d’une augmentation de capital Crossject annonce le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant...

April 30 2024
GlobeNewswire Inc.

Crossject communique ses résultats financiers audités pour 2023

Crossject communique ses résultats financiers audités pour 2023 Dijon, France 25 avril 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), une société pharmaceutique de spécialités qui...

April 25 2024
GlobeNewswire Inc.

Crossject reports audited financial results for 2023

Crossject reports audited financial results for 2023 Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing products...

April 25 2024
GlobeNewswire Inc.

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Information relative au nombre total de droits de vote et d’actions composant...

April 10 2024
GlobeNewswire Inc.

Crossject trading on Euronext to resume as usual on Wednesday April 3

Crossject trading on Euronext to resume as usual on Wednesday April 3 Dijon, France April 2, 2024 – Trading of the stock of Crossject (ISIN: FR0011716265; Euronext: ALCJ) on the Euronext...

April 02 2024
GlobeNewswire Inc.

Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023

Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023 Amélioration notable de la visibilité sur les perspectives règlementaires et...

April 02 2024
GlobeNewswire Inc.

Crossject advances in its U.S. Strategy and reports Financial Results for 2023

Crossject advances in its U.S. Strategy and reports Financial Results for 2023 Increase in visibility in its regulatory and commercialization prospects in the U.S. since latest interactions...

April 02 2024
GlobeNewswire Inc.

Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024

Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024 Dijon, France, 08 mars 2024 – 07:30 CET - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), une société...

March 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.20510.12345679012.0252.281.9769912.02106366DE
40.052.293577981652.182.291.83716372.06172863DE
12-1.035-31.69984686063.2654.281.828967372.93470948DE
26-1.85-45.34313725494.085.961.828996163.88523657DE
52-1.16-34.21828908553.395.961.828712663.87110336DE
156-0.82-26.88524590163.055.961.408918903.40357697DE
2600.2512.62626262631.985.961.041328323.03171601DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
TommyBoyTrader9460 TommyBoyTrader9460 5 minutes ago
Good morning everyone..hope all is well..
Chartmaster Chartmaster 5 minutes ago
Unrestricted OS 6,363,667,435 updated 5/3/2024, no change! Let us know if the Unrestricted Share count changes, if it increases it is dilution
Share Structure: https://www.otcmarkets.com/stock/NSAV/security
NSAV
linkvest linkvest 5 minutes ago
Normally I do too but this defends me, kills all the big bugs and crazy spiders that are down here close to the jungle.. LOL... Yeah she a beautiful blonde keeper... I'd miss her..
IGPK
Inquirig Inquirig 5 minutes ago
She's the crook!!!!!! IMHO
NWBO
DGJR DGJR 6 minutes ago
Benny has been wrong on every price projection over the last 4 plus years. Investors need to do their own DD. IMHO once the processing facility is complete ana d producing, their may be a share price increase. My experience in
plant development from start to commission usually takes 1.5 to 2
AABB
rooster rooster 6 minutes ago
lol well if I was in prison and on work release, posting here would not be on my list of things to do on my release
cojoboy cojoboy 7 minutes ago
Thanks for having my back..dumb sh*t always dig their own graves..I'll supply the shovel..!!!
IGPK
Dj56 Dj56 7 minutes ago
Could a BP be negotiating a deal with a minimum initial purchase price with additional future payments ...IF...certain efficacy emerges and translates into sales?

Am thinking Mark Cuban on Sharktank...offering a set initial price plus % more if certain tiers are met.

Sc
RSPI
Wolf-man jack Wolf-man jack 8 minutes ago
Debt increased. Payout to Cultured Foods?

https://vegconomist.com/investments-finance/investments-acquisitions/cv-sciences-expands-european-plant-based-food-market-acquisition-cultured-foods/
CVSI
Roman516 Roman516 8 minutes ago
Potential value for NWBO's value for DCVax-L and DCVax-D

Had a great discussion with a few research scientist and business owner regarding the potential NVP for NWBO given approval for DCVax-L, IMPO.

Would cancer statistics
https://www.wcrf.org/cancer-trends/worl
NWBO
cojoboy cojoboy 9 minutes ago
God...I hate those ankle biters..lol...😎😎😎😎
IGPK
bar1080 bar1080 9 minutes ago
Berkshire pares huge Apple stake as cash, operating profit set records

SHM: OMAHA, Neb. (Reuters) - Berkshire Hathaway significantly reduced its enormous stake in Apple in the first quarter, as Warren Buffett's conglomerate let its cash hoard swell to a record $189 billion.
BRK.B
misterfishman misterfishman 9 minutes ago
Oh please shut the hell up.if you don't like the stock then sell and go find one you like. We are all here to make money not listen to your bullchit now STFU and let the door hit you on your way out.
IGPK
satter satter 9 minutes ago
For sure but the defense will do likewise for their position.

There are two lawyers who are jurors that could help explain how the charges work.

I always prefer to try to look at it open minded. You can never really tell with Court.
DJT
gfp927z gfp927z 11 minutes ago
Bigworld, >> reevaluate our strategy of remaining in the USA
gimmegimmeminemine gimmegimmeminemine 11 minutes ago
Going back and rereading that PR it does appear the spring trials are going to end without actual fiber production. I and many more were not aware that the spring trials were to just create robust parental lines.

While everything looks to be going great and I'm very happy about it.
KBLB
dranesthesia1 dranesthesia1 12 minutes ago
I did that which is why I bought a bunch of
BLLB
bar1080 bar1080 12 minutes ago
Berkshire pares huge Apple stake as cash, operating profit set records

SHM: OMAHA, Neb. (Reuters) - Berkshire Hathaway significantly reduced its enormous stake in Apple in the first quarter, as Warren Buffett's conglomerate let its cash hoard swell to a record $189 billion.
BRK.A
Hi_Lo Hi_Lo 12 minutes ago
This might also have something to do with it.

https://www.newsfilecorp.com/release/207884/SEC-Charges-Audit-Firm-BF-Borgers-and-Its-Owner-with-Massive-Fraud-Affecting-More-Than-1500-SEC-Filings

What a disaster everything Sharp touches turns into.

The brie
WNFT
ilovetech ilovetech 12 minutes ago
It's why I'm impressed with LP's countermeasures, as we saw with the recent corporate structure change, activation of revimmune, and anything else related. IMO, these gigantic revelations overshadow the beaten down banter which has no impact on the SP imo. If anything, MMs sponsor FUD as potential c
NWBO
kund kund 13 minutes ago
For WGT crowd everything is conspiracy theory, COO just left, he saw better opportunity and he simply left. not pushed out, no buy out, nothing, nada, zilch. For everything in Anavex land has very simple explanation, occam's razor, CEO is incompetent, and he has no desire to bring drug to market. H
AVXL
jrsh jrsh 13 minutes ago
You really trust that slimy weasel with those 24 mills even when all indications.... dilution, no cash, not following the reporting rules for crypto holding... point into another direction???
NSAV
mkt_predictor mkt_predictor 13 minutes ago
Do some DD on the board he’s bringing in too. These guys are impressive and not your usual OTC type leaders. These guys are going to build something impressive with this ticker.
BLLB
oldstocks oldstocks 13 minutes ago
I Just got this TimSykes email

This 10 cent stock DOUBLED in 1 day

On April 15th, Jaguar Health (JAGX) was trading for around $0.10 cents per share.

Because it’s a penny stock, no one was paying attention to it.

But our new AI system sens
JAGX

Your Recent History

EU
ALCJ
Crossject
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved